BRAF and neoplasm: This effect is particularly evident in certain tumor types, such as osteosarcoma93 and non-small cell lung cancer,94 which are highly sensitive to ROS, as well as tumors harboring specific genetic mutations such as KRAS or BRAF mutations.47